A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Status:
Terminated
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
To determine whether, in this patient population, treatment with calcitriol and Naproxen is
more effective in delaying the growth of prostate cancer than treatment with calcitriol alone
as seen in historical controls.